Enomark Pharma Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2016.
2016 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Enomark Pharma Private Limited

Enomark Pharma Private Limited, a active private limited company, was established on 06 June 2016 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909MH2016PTC282093. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.00 Cr.

Formerly known as Aerozest Life Science Private Limited. It upholds a compliant status. Its leadership includes Laxmanram Ruparam Patel (Director), Jetharam Patel (Director), Umesh Ruparam Patel (Director). Past directors included Idanram Bhakarram Patel, Mangalaram Galaramji Choudhary, Jetharam Patel. It holds ₹7.50 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1/A 25, Manali Bldg No. 1 Chs Ltd, Evershine Nagar, Malad West,, Mumbai, Maharashtra, 400064.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909MH2016PTC282093

  • Registration Number

    282093

  • Incorporation Date

    06 June 2016

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹1.00 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 1.00 Cr
  • Company Age 9 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 7.50 Cr
  • Revenue Growth **** -100.00%
  • Profit Growth **** -1146.10%
  • Net Worth 1302.02%
  • Total Assets **** 3721.02%
Company report

Enomark Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Enomark Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Enomark Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Laxmanram Ruparam Patel Director 30 Sep 2023 Current
Jetharam Patel Director 14 Jun 2024 Current
Umesh Ruparam Patel Director 21 Jan 2022 Current
Shriram Sawalram Patel Managing Director 21 Jan 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 22 Jan 2022 Past
Pramod Abcsdd Ceo(Kmp) 22 Jan 2022 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Director 14 Jun 2024 Past
Pramod Abcsdd Director 22 Jan 2022 Past
Pramod Abcsdd Director 06 Dec 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Enomark Pharma.

Enomark Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 1146.1% decrease in profit. The company's net worth Soared by an impressive increase of 1302.02%.

Enomark Pharma revenue growth over time
Enomark Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -100.00%
*******
*******
*******
*******
Revenue from Operations
*******
 -100.00%
*******
*******
*******
*******
Total Assets
*******
 3721.02%
*******
*******
*******
*******
Profit or Loss
*******
 -1146.10%
*******
*******
*******
*******
Net Worth
*******
 1302.02%
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Enomark Pharma?

In 2023, Enomark Pharma had a promoter holding of 100.00%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹75,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 7.50 Cr
Latest Charge Details
Date Lender Amount Status
06 Mar 2024 Others ₹7.50 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Enomark Pharma?

Unlock and access historical data on people associated with Enomark Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Enomark Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enomark Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Enomark Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Enomark Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Charges

    The activity A charge with Others of Rs. 7.50 Cr registered on 06 Mar 2024 with Charge ID 100907656 was modified on 09 Apr 2025. was completed.

  • Balance Sheet

    Enomark Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    The activity Jetharam Patel was appointed as a Director was appointed as a Director on 14 Jun 2024 & has been associated with this company since 1 year 7 months . was completed.

  • Charges

    A charge with Others amounted to Rs. 7.50 Cr with Charge ID 100907656 was registered on 06 Mar 2024. was recorded as a recent event.

  • Director Appointment

    Laxmanram Ruparam Patel was appointed as a Director was appointed as a Director on 30 Sep 2023 & has been associated with this company since 2 years 4 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Enomark Pharma Private Limited?

The CIN of Enomark Pharma Private Limited is U51909MH2016PTC282093.

Where is Enomark Pharma Private Limited headquartered?

Enomark Pharma Private Limited is headquartered at 1/A 25, Manali Bldg No. 1 Chs Ltd, Evershine Nagar, Malad West,, Mumbai, Maharashtra, 400064.

When was Enomark Pharma Private Limited incorporated?

Enomark Pharma Private Limited was incorporated on 06 June 2016.

Who are the current directors of Enomark Pharma Private Limited?

The current directors of Enomark Pharma Private Limited are

What is the primary industry of Enomark Pharma Private Limited?

The primary industry of Enomark Pharma Private Limited is Trade.

Is Enomark Pharma Private Limited a listed company?

Enomark Pharma Private Limited is unlisted.

What is the capital structure of Enomark Pharma Private Limited?

The authorized capital of Enomark Pharma Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.00 Cr.

What is the compliance status of Enomark Pharma Private Limited?

The compliance status of Enomark Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available